全文获取类型
收费全文 | 182978篇 |
免费 | 1345篇 |
国内免费 | 39篇 |
专业分类
耳鼻咽喉 | 1208篇 |
儿科学 | 6824篇 |
妇产科学 | 3237篇 |
基础医学 | 17554篇 |
口腔科学 | 1721篇 |
临床医学 | 13151篇 |
内科学 | 32506篇 |
皮肤病学 | 738篇 |
神经病学 | 17060篇 |
特种医学 | 9157篇 |
外科学 | 29710篇 |
综合类 | 2419篇 |
一般理论 | 13篇 |
预防医学 | 18673篇 |
眼科学 | 2891篇 |
药学 | 10050篇 |
中国医学 | 628篇 |
肿瘤学 | 16822篇 |
出版年
2023年 | 45篇 |
2021年 | 143篇 |
2020年 | 137篇 |
2019年 | 167篇 |
2018年 | 22068篇 |
2017年 | 17487篇 |
2016年 | 19602篇 |
2015年 | 1083篇 |
2014年 | 1020篇 |
2013年 | 1137篇 |
2012年 | 7518篇 |
2011年 | 21546篇 |
2010年 | 19084篇 |
2009年 | 11757篇 |
2008年 | 19959篇 |
2007年 | 22207篇 |
2006年 | 1074篇 |
2005年 | 2669篇 |
2004年 | 3856篇 |
2003年 | 4777篇 |
2002年 | 2970篇 |
2001年 | 337篇 |
2000年 | 475篇 |
1999年 | 256篇 |
1998年 | 289篇 |
1997年 | 279篇 |
1996年 | 153篇 |
1995年 | 182篇 |
1994年 | 158篇 |
1993年 | 118篇 |
1992年 | 97篇 |
1991年 | 152篇 |
1990年 | 170篇 |
1989年 | 117篇 |
1988年 | 91篇 |
1987年 | 73篇 |
1986年 | 63篇 |
1985年 | 65篇 |
1984年 | 57篇 |
1983年 | 47篇 |
1982年 | 81篇 |
1980年 | 65篇 |
1978年 | 33篇 |
1977年 | 34篇 |
1975年 | 31篇 |
1969年 | 32篇 |
1938年 | 61篇 |
1934年 | 30篇 |
1932年 | 56篇 |
1930年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 59 毫秒
1.
2.
Transforming growth factor-β (TGF-β) superfamily signaling via their cognate receptors is frequently modified by TGF-β superfamily co-receptors. Signaling through SMAD-mediated pathways may be enhanced or depressed depending on the specific co-receptor and cell context. This dynamic effect on signaling is further modified by the release of many of the co-receptors from the membrane to generate soluble forms that are often antagonistic to the membrane-bound receptors. The co-receptors discussed here include TβRIII (betaglycan), endoglin, BAMBI, CD109, SCUBE proteins, neuropilins, Cripto-1, MuSK, and RGMs. Dysregulation of these co-receptors can lead to altered TGF-β superfamily signaling that contributes to the pathophysiology of many cancers through regulation of growth, metastatic potential, and the tumor microenvironment. Here we describe the role of several TGF-β superfamily co-receptors on TGF-β superfamily signaling and the impact on cellular and physiological functions with a particular focus on cancer, including a discussion on recent pharmacological advances and potential clinical applications targeting these co-receptors. 相似文献
3.
Shuo-Hsiu Chang Fangshi Zhu Neel Patel Taimoor Afzal Marcie Kern Gerard E. Francisco 《The journal of spinal cord medicine》2020,43(1):126-129
Context: To investigate the feasibility of combining the lower-limb exoskeleton and body weight unweighing technology for assisted walking in tetraplegia following spinal cord injury (SCI).Findings: A 66-year-old participant with a complete SCI at the C7 level, graded on the American Spinal Injury Association Impairment Scale (AIS) as AIS A, participated in nine sessions of overground walking with the assistance from exoskeleton and body weight unweighing system. The participant could tolerate the intensity and ambulate with exoskeleton assistance for a short distance with acceptable and appropriate gait kinematics after training.Conclusion: This report showed that using technology can assist non-ambulatory individuals following SCI to stand and ambulate with assistance which may promote general physical and psychological health if used in the long term. 相似文献
4.
Accuracy and Precision of an Ultrasound-Based Device to Measure the Pelvic Tilt in Several Positions
5.
Nimrat Chatterjee Sanjay D'Souza Mohammad Shabab Cynthia A. Harris Gerard J. Hilinski Gregory L. Verdine Graham C. Walker 《Environmental and molecular mutagenesis》2020,61(8):830-836
Stapled α-helical RIR (Rev1-interacting region) peptides of DNA POL κ bind more effectively to the RIR-interface of the C-terminal recruitment domain of the translesion synthesis DNA polymerase Rev1 than unstapled peptide. The tightest-binding stapled peptide translocates into cells and enhances the cytotoxicity of DNA damaging agents while reducing mutagenesis. Drugs with these characteristics could potentially serve as adjuvants to improve chemotherapy and reduce acquired resistance by inhibiting Rev1-dependent mutagenic translesion synthesis. 相似文献
6.
7.
Randi Sokol Mark Albanese Chiara Albanese Gerard Coste Ellie Grossman Diana Morrill 《Substance Abuse》2020,41(2):174-180
AbstractBackground: Group-based models of Office-Based Opioid Treatment with buprenorphine-naloxone (B/N) are increasingly being implemented in clinical practice to increase access to care and provide additional therapeutic benefits. While previous studies reported these Group-Based Opioid Treatment (GBOT) models are feasible for providers and acceptable to patients, there has been no literature to help providers with the more practical aspects of how to create and maintain GBOT in different outpatient settings. Case series: We present 4 cases of GBOT implementation across a large academic health care system, highlighting various potential approaches for providers who seek to implement GBOT and demonstrate “success” based on feasibility and sustainability of these models. For each case, we describe the pros and cons and detail the personnel and resources involved, patient mix and group format, workflow logistics, monitoring and management, and sustainability components. Discussion: The implementation details illustrate that there is no one-size-fits-all approach, although feasibility is commonly supported by a team-based, patient-centered medical home. This approach includes the capacity for referral to higher levels of mental health and addiction support services and is bolstered by ongoing provider communication and shared resources across the health system. Future research identifying the core and malleable components to implementation, their evidence base, and how they might be influenced by site-specific resources, culture, and other contextual factors can help providers better understand how to implement a GBOT model in their unique clinical environment. 相似文献
8.
9.
Huinan Zhang Jingru Meng Shimeng Zhou Yunhan Liu Di Qu Ling Wang Xubo Li Ning Wang Xiaoxing Luo Xue Ma 《The AAPS journal》2016,18(2):385-394
Exendin-4 is now considered as a promising drug for the treatment of cerebral ischemia. To determine the neuroprotective effects of intranasal exendin-4, C57BL/6J mice were intranasally administered with exendin-4 daily for 7 days before middle cerebral artery occlusion (MCAO) surgery. Intranasally administered exendin-4 produced higher brain concentrations and lower plasma concentrations when compared to identical doses administered interperitoneally. Neurological deficits and volume of infarcted lesions were analyzed 24 h after ischemia. Intranasal administration of exendin-4 exhibited significant neuroprotection in C57BL/6 mice subjected to MCAO by reducing neurological deficit scores and infarct volume. The neuroprotective effects of exendin-4 were blocked by the knockdown of GLP-1R with shRNA. However, exendin-4 has no impact on glucose and insulin levels which indicated that the neuroprotective effect was mediated by the activation of GLP-1R in the brain. Exendin-4 intranasal administration restored the balance between pro- and anti-apoptotic proteins and decreased the expression of Caspase-3. The anti-apoptotic effect was mediated by the cAMP/PKA and PI3K/Akt pathway. These findings provided evidence that exendin-4 intranasal administration exerted a neuroprotective effect mediated by an anti-apoptotic mechanism in MCAO mice and protected neurons against ischemic injury through the GLP-1R pathway in the brain. Intranasal delivery of exendin-4 might be a promising strategy for the treatment of ischemic stroke. 相似文献
10.